You have free access to this content

Journal of Viral Hepatitis

Cover image for Vol. 20 Issue s3

Special Issue: Abstracts for the Viral Hepatitis Congress 2013, 26–28 September 2013, Frankfurt, Germany

September 2013

Volume 20, Issue Supplement s3

Pages 1–44

  1. Keynote Lectures

    1. Top of page
    2. Keynote Lectures
    3. Oral Papers
    4. Poster Sessions
    5. Author Index
    1. You have free access to this content
    2. You have free access to this content
  2. Oral Papers

    1. Top of page
    2. Keynote Lectures
    3. Oral Papers
    4. Poster Sessions
    5. Author Index
    1. O11 Hepatitis C Epidemiology, Screening and Diagnosis

      You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      O114: In vitro infection with HCV increases the suppressive phenotype and activity of the human regulatory T cell (page 3)

      L Ouaguia, O Morales, M Sénéchal, C Wychowski, A Carpentier, L Aoudjehane, Y Calmus, Y de Launoit, F Conti and N Delhem

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12165_2

    4. You have free access to this content
    5. O12 The New Era of HCV Therapies: IFN-Containing Regimens

      You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
    8. O13 The New Era of HCV Therapies: IFN-Free Regimens

      You have free access to this content
    9. You have free access to this content
    10. O14 HCV Comorbidities

      You have free access to this content
      O141: Managing HIV-HCV co-infection (page 7)

      J Rockstroh

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12165_9

    11. You have free access to this content
    12. You have free access to this content
    13. You have free access to this content
    14. O21 Clinical Challenges in Hepatitis C

      You have free access to this content
    15. You have free access to this content
    16. O22 Hepatitis B

      You have free access to this content
    17. You have free access to this content
    18. You have free access to this content
      O225: Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, The Netherlands (pages 10–11)

      G van Rijckevorsel, J Whelan, M Kretzschmar, E Siedenburg, G Sonder, R Geskus, R Coutinho and A van den Hoek

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12165_17

    19. O23 Hepatitis D and E

      You have free access to this content
    20. You have free access to this content
    21. You have free access to this content
    22. O24 Hepatocellular Carcinoma (HCC)

      You have free access to this content
    23. You have free access to this content
    24. You have free access to this content
    25. You have free access to this content
  3. Poster Sessions

    1. Top of page
    2. Keynote Lectures
    3. Oral Papers
    4. Poster Sessions
    5. Author Index
    1. Hepatitis C Virus

      Diagnosis
      You have free access to this content
    2. You have free access to this content
    3. Natural History and Epidemiology
      You have free access to this content
      P3: Unexpected high prevalence of hepatitis C in a densly populated metropolitan area of Germany (page 17)

      B Dogiami, M Ellrichmann, T Breuer, J Otte and W Schmidt

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_2

    4. You have free access to this content
      P4: Epidemiology of hepatitis C virus infections in Finland between the years 1995 and 2011 (pages 17–18)

      M Sillanpää, E Huovinen, M Virtanen, S Toikkanen, H Surcel, H Brummer-Korvenkontio, K Liitsola, I Julkunen, M Salminen, P Ruutu, M Lappalainen, M Färkkilä and M Kuusi

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_3

    5. You have free access to this content
      P5: Prevalence of hepatitis C virus genotypes in four risk groups in the Republic of Macedonia (page 18)

      S Kiprijanovska, K Davalieva, P Noveski, E Sukarova-Stefanovska, D Plaseska-Karanfilska and M Polenakovic

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_4

    6. You have free access to this content
      P6: The risk for hepatitis C infection in blood donors in Cluj County, Romania (pages 18–19)

      G Hatu, M Brumboiu, P Czernichow, I Gorgan and I Bocsan

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_5

    7. Treatment and Late-stage Clinical Trials (Phase IIb, Phase III and Phase IV)
      You have free access to this content
      P7: Combination of fluvastatin and standard of care treatment reduces viral relapse in chronic hepatitis C genotype 1 but not genotype 3 patients (page 19)

      T Selic Kurincic, G Lesnicar, M Poljak, J Meglic Volkar, M Rajter, J Prah, Z Baklan and M Maticic

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_6

    8. Practical Management Strategies
      You have free access to this content
    9. Treatment Monitoring and Predictions of Therapeutic Response
      You have free access to this content
      P9: Distribution of genetic polymorphisms associated to hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population (page 20)

      J Trinks, M Caputo, M Hulaniuk, L Burgos Pratx, V Re, L Fortuny, A Frias, O Torres, F Nunez, A Gadano, D Corach and D Flichman

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_8

    10. You have free access to this content
      P10: Increasing uptake of hepatitis C treatment in England between 2002 and 2010 (pages 20–21)

      S Lattimore, W Irving, S Collins, C Penman and M Ramsay

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_9

    11. You have free access to this content
      P11: Miravirsen does not interact with pegylated interferon-alpha or ribavirin (pages 21–22)

      R Persson, C Wynne, A Levin, B King, T Boyea, K Zeh and M Hodges

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_10

    12. You have free access to this content
      P12: Miravirsen does not interact with telaprevir (page 22)

      R Persson, A Karim, J Rodriguez-Orengo, A Levin, B King, A Chen, K Zeh and M Hodges

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_11

    13. You have free access to this content
    14. You have free access to this content
      P14: HepatiC, the viral hepatitis C patients management application and database (pages 23–24)

      C Sayada, R Boulme, D Gonzalez, M Barallon, C Fernández-Carrillo, X Forns, M Buti, J Esteban, J Quer and J Calleja

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_13

    15. You have free access to this content
    16. You have free access to this content
      P16: Analysis of genetic determinants associated with therapy response against hepatitis C virus: first study of IL28B polymorphisms in Uruguayan patients (pages 24–25)

      N Echeverría-Chagas, S Fischer, S Boschi, R Uriarte, J Angulo, M López-Lastra, G Moratorio, J Cristina and P Moreno

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_15

    17. You have free access to this content
    18. Preclinical and Early Clinical Development (Phase I and Phase IIa)
      You have free access to this content
      P18: Samatasvir (IDX719), a potent pan-genotypic HCV NS5A inhibitor (pages 25–26)

      D Mayers, IDX-06A-001 Investigator Team and IDX719 Clinical Development Team

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_17

    19. Other
      You have free access to this content
      P19: Ribavirin-boronic acid loaded nanoparticles: a possible route to improve hepatitis C treatment (pages 26–27)

      Y Abo-zeid, W Irving, B Thomson, G Mantovani and M Garnett

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_18

    20. You have free access to this content
      P20: Understanding the impact of a cure for hepatitis C from the patient perspective (pages 27–28)

      S Lane, S Cline, S Szabo, K Beusterien, E Hautamaki, D Bernstein, Y Liu and K Gooch

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_19

    21. You have free access to this content
      P21: Analysing the human serological response for HCV and eight other pathogens with a multiplexed antigen array (page 28)

      A Filomena, J Göpfert, D Duffy, M Albert, T Joos, T Joos and N Schneiderhan-Marra

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_20

    22. You have free access to this content
    23. Hepatitis B Virus

      Diagnosis and Monitoring
      You have free access to this content
      P23: Role of innate immune response in acute viral hepatitis (page 29)

      M Magdy Abd El Razek, M El Sayed Zaki and H Abd El Razek

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_22

    24. You have free access to this content
      P24: Occult hepatitis B infection among vaccinated cohort (page 30)

      S Hudu, Z Sekawi, N Taib, Y Malik and N Harmal

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_23

    25. You have free access to this content
    26. You have free access to this content
    27. You have free access to this content
      P27: Estimating transmission rates of hepatitis B (HBV) in households of HBV infected pregnant women in London (page 31)

      P Keel, S Ijaz, J Poh, G Edwards, G Nixon, J Flood, K Beebeejaun, J Shute, A Millar, J Parry, R Tedder, M Ramsay and G Amirthalingam

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_26

    28. Natural History and Epidemiology
      You have free access to this content
      P28: In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes (pages 31–32)

      J Trinks, M Sugiyama, Y Tanaka, F Kurbanov, J Benetucci, E Gimenez, M Weissenbacher, M Mizokami and J Oubina

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_27

    29. You have free access to this content
      P29: Implementation of a reliable, low cost, in-house quantitative-PCR method to measure hepatitis B virus viral load in sub-Saharan Africa (page 32)

      H Njai, A Ceesay, L Johnson, R Njie, T Corrah, U Dalessandro, M Thurz, M Mendy and I Chemin

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_28

    30. You have free access to this content
    31. You have free access to this content
      P31: Sero-prevalance of HBV among university students in Sargodha, Pakistan (page 33)

      S Khan, M Ajmal, A Yousaf, M Iftikhar, H Tahir, M Arshad and S Nawaz

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_30

    32. Practical Management Strategies
      You have free access to this content
    33. You have free access to this content
      P33 (page 34)

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_32

    34. Other
      You have free access to this content
      P34: Characterization of the CD8+ T-cell immune response to the hepatitis B virus in the chronic and immunologically controlled infection (page 34)

      H Kefalakes, C Jochum, G Hilgard, A Kahraman, A Bohrer, N El Hindy, G Gerken and J Timm

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_33

    35. You have free access to this content
      P35: Molecular characterization of partial and full-length genome of the hepatitis B virus among chronic patients in the São Paulo city, Brazil (page 35)

      L Santana, N Mantovani, M Cicero, R Arnold, R Azevedo, D de Sa Filho, P Ferreira, R Diaz and S Komninakis

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_34

    36. You have free access to this content
    37. You have free access to this content
      P37: Quantification of hepatitis B virus covalently closed circular DNA in sera of chronic hepatitis B patients (page 36)

      B Singla, Y Chawla, A Chakraborti, S Arora, A Das, R Dhiman and A Duseja

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_36

    38. You have free access to this content
    39. Hepatocellular Carcinoma

      You have free access to this content
      P39: Genetic polymorphism of CCR6 (rs 2301436) increases susceptibility of HCC and promotes tumor progression in HCV-G4 infected Egyptian patients (pages 36–37)

      M Abu El- Makarim, R Bakry, A Amin, A El- Akad, E Soliman, M Shatat, R Mahmoud and S Hamdy

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_38

    40. HIV Co-infection and Viral Hepatitis

      You have free access to this content
    41. You have free access to this content
    42. Viral Hepatitis A, D and E

      You have free access to this content
      P42: Full length genome characterization of hepatitis delta virus in the Amazon region of Brazil, using dried-blood samples collection (pages 38–39)

      M Cicero, N Mantovani, L Santana, R Arnold, R Azevedo, D Sá-Filho, R Diaz and S Komninakis

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_41

    43. You have free access to this content
      P43: Hepatitis E and acute liver injury in Scotland, UK (page 39)

      C Crossan, K Simpson, D Craig, J Davidson, C Bellamy, H Dalton and L Scobie

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_42

    44. You have free access to this content
      P44: Reduction in CD4+T cells and altered monocytes/macrophages is associated with fatal acute liver failure hepatitis E virus infected pregnant patients (pages 39–40)

      R Sehgal, P David, A Vyas, P Rawal, S Hissar, G Samudrala, S Patra, S Trivedi, S Sarin and N Trehanpati

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_43

    45. You have free access to this content
      P45: Are porcine derived pharmaceuticals a source of hepatitis E virus infection? (page 40)

      C Crossan, L Scobie, J Godwin, J Hunter, T Hawkes and H Dalton

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_44

    46. You have free access to this content
      P46: Hepatitis E viral seroprevalence among multiple transfused Egyptian children (pages 40–41)

      M El Sayed Zaki, H Magdy Abd El Razek and M Magdy Abd El Razek

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_45

    47. You have free access to this content
      P47: Hepatitis E and Scottish liver transplant recipients (page 41)

      C Crossan, H Dalton, L Scobie, K Simpson and J Davidson

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_46

    48. You have free access to this content
      P6A: Role of IL-12B and IL-28B gene polymorphisms in families of HCV infected patients in the Nile Delta of Egypt (pages 41–42)

      N Elwan, F Assal, A El-Fert, S Shalaby, L Effat, K Sayed, A Edrees, L AboAli and M Abdel-Hamid

      Article first published online: 23 OCT 2013 | DOI: 10.1111/jvh.12166_47

  4. Author Index

    1. Top of page
    2. Keynote Lectures
    3. Oral Papers
    4. Poster Sessions
    5. Author Index
    1. You have free access to this content
      Author Index (pages 43–44)

      Article first published online: 23 SEP 2013 | DOI: 10.1111/jvh.12167

SEARCH

SEARCH BY CITATION